EBS·29089Q105·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G
EBS (Emergent BioSolutions Inc) is held by 99 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($36M), STATE STREET CORP ($23.7M), DIMENSIONAL FUND ADVISORS LP ($22.9M). Net institutional sentiment: Mixed.
Showing 1-20 of 106
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer